Kai Yuan
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 09, 2026
Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability.Yi Hou, Xinqing Zheng, Yiwen Zhang
|Feb 04, 2026
Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma.Wenjian Min, Junfeng He, Qiman Zhang
|Dec 09, 2025
Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance.Kai Yuan, Wanqi Wang, Chen Tong
|Jun 03, 2025
Discovery of a Novel and Potent MET Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC.Wenjian Min, Chunling Chen, Zhongrui Shi
|Apr 14, 2025
Development of Novel PRMT7 Inhibitors for the Treatment of Prostate Cancer.Jiaxing Li, Chengliang Sun, Ying Zhang
|Jul 04, 2024
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment.Wenjian Min, Huanaoyu Yang, Dawei Wang
Pageof 2
